Evidence map›Paper›PMID 40831095›Full record

Trial reportMicrocirculation (New York, N.Y. : 1994)2025

Coronary Microvascular Dysfunction Alters the Pulsatile Behavior of the Resting Coronary Blood Flow.

Ahmet Tas, Yaren Alan, Ilke Kara Tas, Omer E Aydin, Zeynep Atay, Sule Yilmaz, Alp Ozcan, Tim P van de Hoef, Sabahattin Umman, Jan J Piek Md and 1 more

Registry-linked trialAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Microcirculation (New York, N.Y. : 1994), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02328820 (DEFINE-FLOW), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02328820 nacompletednot on this map

DEFINE-FLOW (Distal Evaluation of Functional Performance With Intravascular Sensors to Assess the Narrowing Effect - Combined Pressure and Doppler FLOW Velocity Measurements)

TypeinterventionalSponsorThe University of Texas Health Science Center, HoustonRan2014 to 2021Enrolled455ConditionsCoronary Artery DiseaseArmsPercutaneous coronary intervention (PCI), Optimal medical therapy (OMT)
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ahmet TasDepartment of Cardiology, Amsterdam UMC, Heart Centre, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.ORCID 0000-0002-1944-2576
Yaren AlanFaculty of Medicine, Istanbul University, Istanbul, Turkey.ORCID 0000-0002-6204-2391
Ilke Kara TasEmergency Department, Gomec State Hospital, Balikesir, Turkey.
Omer E AydinFaculty of Computer and Information Sciences, Yeditepe University, Istanbul, Turkey.
Zeynep AtayFaculty of Medicine, Istanbul University, Istanbul, Turkey.
Sule YilmazFaculty of Medicine, Istanbul University, Istanbul, Turkey.
Alp OzcanFaculty of Medicine, Istanbul University, Istanbul, Turkey.ORCID 0000-0002-5558-6155
Tim P van de HoefDepartment of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands.
Sabahattin UmmanFaculty of Medicine, Istanbul University, Istanbul, Turkey.
Jan J Piek MdDepartment of Cardiology, Amsterdam UMC, Heart Centre, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
Murat SezerDepartment of Cardiology, Acibadem International Hospital, Istanbul, Turkey.ORCID 0000-0001-9614-1614

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVariations in resting pulsatile coronary flow velocity acceleration/deceleration characteristics (dU/dt) with respect to epicardial lesions and coronary microvascular dysfunction (CMD) remain incompletely understood.

methodThe coronary dU/dt pattern was extracted from the first derivative of the intracoronary Doppler velocity signal. Univariable and multivariable models evaluated the relationships between the dU/dt amplitudes, epicardial disease as well as CMD, defined by a blunted coronary flow reserve (CFR) adjusted for the concomitant epicardial disease severity (fractional flow reserve, FFR) yielding the microvascular resistance reserve (MRR). Functional CMD was defined by a blunted MRR (≤ 3.0) but normal hyperemic microvascular resistance (hMR < 2.5) whereas structural CMD was defined by a blunted MRR (≤ 3.0) combined with increased hMR (≥ 2.5). Six major acceleration or deceleration peaks were identified in each cardiac cycle; these were a (amplitude of peak diastolic acceleration), b (amplitude of early diastolic deceleration nadir), c (amplitude of peak diastolic re-acceleration), j (amplitude of end-diastolic deceleration nadir), x (amplitude of peak systolic acceleration), and z (amplitude of end-systolic deceleration nadir) waves.

resultsFunctional CMD was associated with amplification of a (β = 55.944, 95% CI [21.112, 90.777], p = 0.002) and × (β = 44.069, 95% CI [20.182, 67.955], p < 0.001), b (β = -34.019, 95% CI [-50.865, -17.173], p < 0.001), j (β = -48.723, 95% CI [-71.272, -26.174], p < 0.001), and z (β = -31.047, 95% CI [-53.596, -8.498], p = 0.007) waves. Structural CMD was associated with blunted a (β = -76.938, 95% CI [-113.125, -40.751], p < 0.001) and j (β = 24.787, 95% CI [1.361, 48.213], p = 0.039).

conclusionEpicardial disease severity is minimally associated with alterations in the resting dU/dt pattern, whereas CMD endotypes are associated with distinctively altered intrabeat pulsatility characteristics. Stronger acceleration magnitudes at rest do not indicate a healthier microcirculation or absence of CMD.

trial registrationClinicalTrials.gov (NCT02328820).

Indexed as

Coronary Artery DiseaseCoronary CirculationCoronary VesselsMicrocirculationPulsatile FlowAgedBlood Flow VelocityFemaleFractional Flow Reserve, MyocardialHumansMaleMiddle AgedRestcoronary flow accelerationcoronary flow reservecoronary microvascular dysfunctionmicrovascular resistance reserveresting coronary flow

Identifiers

PMID40831095
PMCPMC12365450

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.